Chemical Technology

Collaboration is “the name of the game” to build resilience, say speakers at 12th GPCA Supply Chain Conference

The virtual conference was held on 26-27 May, attracting over 1300 attendees from 450 companies in 62 countries

Dubai, United Arab Emirates, 31 May 2021 – The coronavirus (COVID-19) pandemic of the last 15 months has demonstrated the acute importance of collaboration to build more agile, resilient, and responsive supply chains, said industry leaders at the 12th Gulf Petrochemicals and Chemicals Association (GPCA) Supply Chain Conference held virtually on 26-27 May.

Senior executives from across the chemical and petrochemical value chain, logistics service providers and shipping operators urged industry leaders to capitalize on the lessons learned during the pandemic and act upon them in the future – from collaborating more closely with the regulators, their customers, and strategic partners, to driving better supply chain visibility, investing in digitalization, building their workforce capabilities, and focusing on supply chain sustainability.

In his keynote address, Hamad Alterkait, Chairman of the Kuwait based company, PIC, encouraged chemical leaders to engage in supply chain collaboration even with their competitors and keep their inventory in close customer proximity to improve their reliability and better serve their end markets. He told attendees at the virtual event: “Regional chemical producers must diversify their supply base even if it means incurring higher costs in order to cushion the impact from any future crisis. Companies must also explore out of the box supply chain solutions, using different scenarios, which may aid in addressing important challenges at a critical time.”

Echoing Alterkait’s remarks on the importance of collaboration were Hosam Al-Zamil, VP, Global Supply Chain, SABIC; Ahmed Abdulla Al-Salahi, CCO, Q-Chem; and Ahmed Al-Katheeri, SVP - Supply Chain Management, Borouge, in the conference’s inaugural panel on the future of chemical supply chains. The COVID-19 pandemic was a test to chemical supply chains’ resilience, as it demonstrated that the world is one global community, panelists said.

“The future will not be the moving of our products; it will be the moving of data which will help enable responsiveness and agility and drive customer centricity to stay competitive. However, we cannot achieve this by working in silos. The chemical industry is just one part of the supply chain and we must work together to build a more resilient future,” Al-Katheeri added.

A recent GPCA survey confirms the insights shared by speakers. It found that chemical supply chain and operations have been the single most impacted business function within downstream organizations in the GCC in the past 15 months as a result of the COVID-19 pandemic. In the path to recovery, chemical companies must focus on supply chain digitalization, sustainability, trade facilitation and regulatory engagement. Within these trends, carbon neutrality, Artificial Intelligence (AI) and Machine Learning (ML) will be the key segments to focus on and drive the highest impact on businesses’ supply chains today, the survey found.

Dr. Abdulwahab Al-Sadoun, Secretary General, GPCA, commented, “I was pleased to welcome the regional and global chemical industry to the virtual edition of the 12th GPCA Supply Chain Conference last week and gain first-hand insight into the challenges associated with the pandemic on their chemical supply chain and operations. The audience was left with a message of positivity on what’s to come next and provided with a range of practical tips on how to address the uncertainty and any new crisis in the future. I hope delegates enjoyed attending the event and thank all our sponsors and partners for making this edition possible.”

The 12th GPCA Supply Chain Conference was held under the theme ‘Powering a resilient, responsive and agile supply chain’, attracting over 1300 attendees from 450 companies in 62 countries.

To learn more, visit

About the Gulf Petrochemicals & Chemicals Association
The Gulf Petrochemicals and Chemicals Association (GPCA) was established in 2006 to represent the downstream hydrocarbon industry in the Arabian Gulf. Today, the association voices the common interests of more than 250 member companies from the chemical and allied industries, accounting for over 95 percent of chemical output in the GCC. The industry makes up the second largest manufacturing sector in the region, producing over USD 108 billion worth of products every year.

GPCA supports the petrochemical and chemical industry in the Arabian Gulf through advocacy, networking and thought leadership initiatives aimed at helping member companies to connect, share and advance knowledge, contribute to international dialogue, and become prime influencers in shaping the future of the global petrochemicals industry.

Committed to providing a regional platform for stakeholders from around the world, GPCA manages six working committees – Plastics, Supply Chain, Fertilizers, International Trade, Research and Innovation, and Responsible Care – and organizes six world-class events each year. The association also publishes an annual report, regular newsletters and various other industry reports.

For more information, visit

Slavka Atanasova
Gulf Petrochemicals and Chemicals Association   
P. O. Box 123055,    
United Arab Emirates    
T: + 44 7561 525126
Hector Aquino


Other News
Chemical Management

Sapio Sciences Unifies Small- and Large-Molecule Discovery on a Single Platform

Business Wire | October 10, 2023

Sapio Sciences, the science-aware™ lab informatics platform, today announced the launch of the Sapio Chemistry solution, which unifies small-molecule and large-molecule discovery workflows on a single platform. Built on the same no-code platform as Sapio’s existing large-molecule discovery electronic lab notebook solution, Sapio Chemistry enables scientists to draw insights across all their organization’s discovery experiments. See Sapio’s new Chemistry solution for yourself in this exclusive webinar on October 11, 2023 - register here. “Many organizations are still running decades-old electronic laboratory notebooks (ELNs) and other software for capturing chemical synthesis experiments and registering small molecules,” said Kevin Cramer, president and CEO of Sapio Sciences. “Large-molecule and small-molecule discovery have traditionally been managed on disparate systems, creating artificial islands that impede scientific collaboration and decision-making. Sapio is excited to give biopharma organizations the opportunity to consolidate all their chemistry experiments on a modern, unified lab platform.” Sapio Chemistry is designed to facilitate collaboration among chemistry teams and their colleagues in analytical core facilities and screening labs, including contract research organizations. Advanced, chemically intelligent search built into Sapio Chemistry makes up-to-date project data easily accessible to the entire team. Out-of-the-box, configurable templates simplify the capture and sharing of chemistry experiments, including the reaction, reagents, solvents, and products through to registering synthesized compounds, batches, and lots and requesting assays. Sapio Chemistry also includes advanced capabilities for sample and inventory management, leveraging the strong sample-handling features built into the Sapio platform. Sapio Chemistry includes the latest science-aware™ functionality from Sapio, offering the first-ever lab triple-play solution of ELN, laboratory information management system (LIMS), and Jarvis scientific data cloud all in one. Science-aware means the system unifies data and works the way scientists do with built-in tools for managing, visualizing, and analyzing data to make life in the lab simple. About Sapio Sciences Sapio Sciences' mission is to improve life in the lab — because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware™ lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions. Sapio serves some of the largest global and niche brands, including biopharma, CROs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, stability, clinical, histopathology, drug research, and in vivo studies.

Read More

Chemical Management

Actylis Launches a New cGMP WFI Generation, Storage, and Distribution System with Additional ISO Class 7 Manufacturing Space

businesswire | September 26, 2023

Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations. Gilles Cottier, CEO at Actylis, said: “Today we are delighted to announce the opening of this new WFI system at our Baie d’Urfé site. Investment in this new WFI generation, storage, and distribution system reflects our ongoing commitment to support our customers, and to continuously develop our range of products and services. The new system positions us to be a preferred outsource partner for our customers’ buffer solutions. We understand that capacity is often a pinch-point for our customers, and we are delighted to be able to propose this option to them.” Damien O’Rourke, SVP Manufacturing Operations at Actylis added: “Our new WFI system, redundant with our Limerick, Ireland WFI capabilities, incorporates the latest advancements in water purification technology, adhering to Good Manufacturing Practices (cGMP) that guarantees the production of WFI that meets or exceeds the most rigorous quality standards. In addition to the services this enables for our customers, the investment provides Actylis and our customers with a robust multi-site business continuity plan to ensure dependable supply.” Jean-Francois Raymond, Site Director, elaborated on some of the specifics of the system: “We are excited to have this new system here at Baie d’Urfé come on stream. The WFI system is fully qualified with all supporting validation documents, and is capable of generating and maintaining water as per required USP and PhEur/BP specifications of Water for Injection.” The new system’s strategic location in Montreal positions it as a pivotal hub for biopharmaceutical companies across North America and beyond. Its proximity to major transportation networks ensures timely distribution of WFI to manufacturers, enabling them to streamline their production processes and meet growing market demands. About Actylis Actylis is a leading global manufacturer and supplier of differentiated specialty ingredients to life sciences and specialty chemicals end markets. With business operations in ten countries, Actylis manufactures and supplies over 4,500 chemical compounds used principally by the pharmaceutical, biopharmaceutical, nutritional, agricultural and specialty chemical industries. Building on a series of strategic acquisitions, Actylis has integrated their manufacturing, R&D, quality, and sourcing capabilities to create a worldwide supplier of critical raw materials that includes a robust manufacturing footprint. Its global operations include a significant presence on the ground in North America, Europe, India, and China. Actylis is well positioned to innovate new solutions, ensure quality, and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide.

Read More

Chemical Management

Lummus and RWDC Announce Agreement to Accelerate and Scale PHA Production

prnewswire | September 12, 2023

Lummus Technology, a global provider of process technologies and value-driven energy solutions, and RWDC Industries, a biotechnology company developing biopolymer material solutions, announced a binding Joint Development and Commercial Cooperation Agreement (JDCCA) to rapidly expand manufacturing and global licensing of polyhydroxyalkanoates (PHA). In April, Lummus and RWDC signed a memorandum of understanding (MOU) to cooperate on global PHA deployment initiatives. "This agreement highlights Lummus and RWDC's strong commitment to addressing plastic waste and the carbon footprint associated with conventional plastics production," said Leon de Bruyn, Lummus Technology's President and Chief Executive Officer. "Our partnership in this innovative space aligns with the United Nations' Sustainable Development Goals, reflecting our ongoing dedication to developing technologies that accelerate the use and availability of eco-friendly plastics." "We look forward to the value that will be created in combining Lummus' expertise with ours to improve people's lives and health by making PHA polymers and resins available at large scale," said Dr. Daniel Carraway, RWDC's Chief Executive Officer. "It has always been our goal to develop sustainable materials that benefit every living thing on the planet, and this partnership is a monumental step in that direction. Lummus' and RWDC's decision to work together is an exciting development toward making it possible for more people to benefit from natural materials while preserving resources and our environment for future generations." RWDC uses plant-based oils, including post-consumer or waste cooking oils, to produce its proprietary Solon™ PHA, which can be organically recycled or composted in home and industrial composting facilities. Products or packaging made with PHA that find their way into the environment, therefore, will fully biodegrade in soil, fresh water, and marine settings, preventing persistent plastics and microplastics from accumulating in the environment. Articles produced with PHA also can be recycled, re-used or returned to the carbon cycle by way of organic recycling or composting systems. Lummus' interest in pursuing this partnership is testament to RWDC's attractiveness to licensors, due to its demonstrable technology innovation and technical capabilities; commercial value proposition and unit economics; and existing global brand partnerships that continuously validate market demand. RWDC is uniquely positioned as the only PHA manufacturer in the market to provide scalable and cost-effective biopolymer production and first- and best-in-class formulation capabilities and guidance on conversion for product development. Licensing and technology development through its forthcoming partnership with Lummus further enhances RWDC's position as a market leader. Moreover, Lummus' polymer expertise, illustrated through its Novolen® polypropylene technology, highlights a commitment to innovation and sustainable solutions in polyolefin technology to drive transformative change within the plastics industry. About Lummus Lummus Technology is the global leader in developing technology solutions that make modern life possible and focus on a more sustainable, low carbon future. We license process technologies in clean fuels, renewables, petrochemicals, polymers, gas processing and supply lifecycle services, catalysts, proprietary equipment and digitalization to customers worldwide. About RWDC Industries Founded in 2016, RWDC Industries is a biotechnology company that utilizes natural processes to produce materials for use in our daily lives. RWDC develops innovative, cost-effective biopolymer material solutions, including Solon™ PHA, a fully biodegradable and environmentally safe material that can replace plastic in a wide range of applications from single use articles to consumer goods or food packaging to non-wovens and textiles. RWDC supports sustainable practices and encourages responsible choice in plastic waste management, including recycling, to protect our environment and planet. Its global headquarters is in Singapore and operational headquarters is in Athens, Georgia.

Read More

Chemical Management

Syzygy Plasmonics Signs Strategic Investment Agreement with Mitsubishi Heavy Industries

PR Newswire | October 12, 2023

Syzygy Plasmonics announced today that it has reached a strategic investment agreement with Mitsubishi Heavy Industries, Ltd. (MHI), executed through Mitsubishi Heavy Industries America, Inc. (MHIA). The agreement formalizes ties between Syzygy and MHIA, giving the global multinational engineering and manufacturing technology company greater insight into Syzygy's strategic priorities and an opportunity to support Syzygy's business execution plans. "MHIA has been making moves to establish themselves as one of the leaders in the energy transition," said Syzygy Chief Executive Officer Trevor Best. "Formalizing our relationship with them shows their commitment to helping scale cutting edge technology and opens up new avenues for Syzygy and MHIA to work together as we commercialize our industrial decarbonization platform." Syzygy Plasmonics Syzygy Plasmonics is a deep-decarbonization company. It builds reactors that use light instead of heat to electrify chemical manufacturing and power a cleaner, safer world. Utilizing technology licensed from Rice University and advanced engineering, Syzygy is commercializing a universal photocatalytic reactor platform. When powered with renewable electricity, this tunable technology is designed to reduce both cost and emissions from many different chemical reactions. Starting with solutions designed to consume greenhouse gases and produce low- and zero-emissions hydrogen, the company's mission is to create a world where chemicals, fuels, and fertilizer are low cost, carbon neutral, and accessible to everyone. Mitsubishi Heavy Industries Group Mitsubishi Heavy Industries Group is committed to building a business that contributes to realizing a decarbonized society while investing in and collaborating with various partners with innovative technologies. This investment will help Syzygy Plasmonics to accelerate commercialization and continue its development of innovative alternative technologies, particularly those that contribute to the hydrogen ecosystem and CO2 ecosystem. Going forward, MHI will continue to enhance and diversify its solutions portfolio, providing its customers with alternative decarbonization technologies to reach their net zero goals.

Read More